Literature DB >> 16434608

No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites.

Robert C Millikan1, Kimberley Heard, Scott Winkel, Edgar J Hill, Kristin Heard, Beri Massa, Lydia Mayes, Patricia Williams, Rachel Holston, Kathleen Conway, Sharon Edmiston, Allan René de Cotret.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16434608     DOI： 10.1158/1055-9965.EPI-05-0692

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  18 in total

1.  ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer.

Authors:  Elif Akisik; Hulya Yazici; Nejat Dalay
Journal:  Mol Biol Rep       Date:  2010-04-01       Impact factor: 2.316

2.  MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis.

Authors:  Erjiang Zhao; Dan Cui; Ling Yuan; Weiquan Lu
Journal:  Mol Biol Rep       Date:  2011-07-03       Impact factor: 2.316

3.  Lack of an Association between a Functional Polymorphism in the MDM2 Promoter and Breast Cancer in Women in Northeast Iran.

Authors:  Zeinab Tavakkol Afshari; Amin Reza Nikpoor; Jalil Tavakkol Afshari; Rashin Ganjali; Parvaneh Sanglakh Ghoochan Atigh; Fatemeh Homaei Shandiz; Khadijeh Jamialahmadi
Journal:  Rep Biochem Mol Biol       Date:  2017-10

4.  Involvement of single-nucleotide polymorphisms in predisposition to head and neck cancer in Saudi Arabia.

Authors:  Khaled S Al-Hadyan; Najla M Al-Harbi; Sara S Al-Qahtani; Ghazi A Alsbeih
Journal:  Genet Test Mol Biomarkers       Date:  2011-08-30

5.  Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population.

Authors:  Jyh-Der Leu; I-Feng Lin; Ying-Fang Sun; Su-Mei Chen; Chih-Chao Liu; Yi-Jang Lee
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

6.  No association of MDM2 SNP309 with risk of glioblastoma and prognosis.

Authors:  Soufiane El Hallani; Yannick Marie; Ahmed Idbaih; Mathieu Rodero; Blandine Boisselier; Florence Laigle-Donadey; François Ducray; Jean-Yves Delattre; Marc Sanson
Journal:  J Neurooncol       Date:  2007-06-14       Impact factor: 4.130

7.  Haplotype structure and selection of the MDM2 oncogene in humans.

Authors:  Gurinder Singh Atwal; Gareth L Bond; Sally Metsuyanim; Moshe Papa; Eitan Friedman; Tal Distelman-Menachem; Edna Ben Asher; Doron Lancet; David A Ross; John Sninsky; Tomas J White; Arnold J Levine; Ronit Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

8.  MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.

Authors:  Yan Wan; Wei Wu; Zhihua Yin; Peng Guan; Baosen Zhou
Journal:  BMC Cancer       Date:  2011-05-29       Impact factor: 4.430

9.  Polymorphisms in promoter sequences of MDM2, p53, and p16 genes in normal Japanese individuals.

Authors:  Yasuhito Ohsaka; Hoyoku Nishino
Journal:  Genet Mol Biol       Date:  2010-12-01       Impact factor: 1.771

10.  Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer.

Authors:  Ying-Fang Sun; Jyh-Der Leu; Su-Mei Chen; I-Feng Lin; Yi-Jang Lee
Journal:  BMC Cancer       Date:  2009-01-13       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.